vicc Archives
Vanderbilt professor named chair of biomedical engineering
Mar. 26, 2008—Todd D. Giorgio, professor of biomedical engineering, has been named chair of the Department of Biomedical Engineering at Vanderbilt University.
Racial Disparities Persist for Colonoscopy Screenings
Mar. 26, 2008—African-Americans are far more likely to be diagnosed with and to die from colorectal cancer than whites or other minority groups. Despite this increased risk, a new study led by Vanderbilt University Medical Center researchers found that African-Americans are far less likely to undergo colonoscopy screening than whites, even when both groups have a family history of colorectal cancer. The study was published in the March 24 issue of the Archives of Internal Medicine.
Vanderbilt-Ingram Cancer Center named Blue Distinction Center for Complex and Rare CancersSM
Mar. 13, 2008—Vanderbilt-Ingram Cancer Center has been selected as a Blue Distinction Center for Complex and Rare CancersSM by Blue Cross Blue Shield Association, in collaboration with BlueCross BlueShield of Tennessee.
Vanderbilt-Ingram Researchers Find Clue to Cancer Drug Allergies
Mar. 13, 2008—Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country.
Link Found Between Vegetables and Decreased Risk of Breast Cancer
Mar. 7, 2008—When your mother told you to eat your vegetables it appears that maternal wisdom had a scientific basis. Researchers with Vanderbilt-Ingram Cancer Center and the Shanghai Cancer Institute in China have discovered a possible link between a diet rich in certain vegetables and a decreased risk for breast cancer. The study appears in the March issue of the American Journal of Clinical Nutrition.
Pietenpol Chosen to Lead Vanderbilt-Ingram Cancer Center
Jan. 17, 2008—Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center.
New review clears silicone gel breast implants of serious health risks; Vanderbilt-Ingram Cancer Center researchers find no cancer link
Oct. 25, 2007—Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants.
Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure
Aug. 29, 2007—Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.
Vanderbilt-Ingram clinic space expanding to meet needs of patients
Feb. 23, 2007— When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond.
Vanderbilt-Ingram Cancer Center Receives Highest Level of Approval
Feb. 22, 2007— Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS).
Vanderbilt-Ingram Cancer Center receives $6.5 million grant to study tumor environment
Jan. 29, 2007— Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body -- something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI).
Pietenpol Named Interim Director of Vanderbilt-Ingram Cancer Center
Jan. 29, 2007— Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director.
